MIGLIACCIO, Antimo
 Distribuzione geografica
Continente #
EU - Europa 8.664
NA - Nord America 4.387
AS - Asia 3.771
SA - Sud America 553
AF - Africa 49
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.434
Nazione #
RU - Federazione Russa 5.109
US - Stati Uniti d'America 4.324
SG - Singapore 1.243
IE - Irlanda 1.017
CN - Cina 876
IT - Italia 762
HK - Hong Kong 568
UA - Ucraina 488
BR - Brasile 473
GB - Regno Unito 428
TR - Turchia 296
DE - Germania 292
IN - India 268
KR - Corea 197
FI - Finlandia 158
VN - Vietnam 138
SE - Svezia 123
GR - Grecia 81
FR - Francia 80
JP - Giappone 70
BE - Belgio 44
AR - Argentina 35
CA - Canada 29
BD - Bangladesh 23
MX - Messico 21
ID - Indonesia 16
PK - Pakistan 15
AT - Austria 13
EC - Ecuador 13
NL - Olanda 13
IQ - Iraq 12
ZA - Sudafrica 12
PL - Polonia 11
ES - Italia 9
IR - Iran 8
MA - Marocco 8
PY - Paraguay 8
VE - Venezuela 8
EG - Egitto 7
JO - Giordania 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
AE - Emirati Arabi Uniti 4
CO - Colombia 4
DZ - Algeria 4
HU - Ungheria 4
KE - Kenya 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
SA - Arabia Saudita 4
UY - Uruguay 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IL - Israele 3
PE - Perù 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
AU - Australia 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
DK - Danimarca 2
HR - Croazia 2
MK - Macedonia 2
PH - Filippine 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
NP - Nepal 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 17.432
Città #
Moscow 1.828
Dublin 1.010
Jacksonville 742
Chandler 718
Santa Clara 601
Singapore 574
Hong Kong 567
Bengaluru 246
Ann Arbor 206
Seoul 186
Beijing 151
Princeton 144
Hefei 143
Caserta 129
Naples 129
Ashburn 128
Medford 109
Boardman 106
Roxbury 88
Istanbul 82
Wilmington 82
Bremen 75
Woodbridge 73
Dallas 60
San Mateo 60
The Dalles 49
Brussels 44
Ho Chi Minh City 44
Nanjing 44
São Paulo 41
Los Angeles 40
Cambridge 37
Hanoi 31
Houston 30
Munich 30
Jinan 29
New York 29
Mountain View 28
Rome 28
Napoli 25
Turku 25
Aversa 24
Des Moines 23
Pozzuoli 21
Rio de Janeiro 21
Nanchang 20
Shenyang 20
Kunming 17
Norwalk 17
Frattamaggiore 13
Guangzhou 13
Afragola 12
Milan 12
Belo Horizonte 11
Marano 11
Zhengzhou 11
Seattle 10
Somma Vesuviana 10
Vienna 10
Boston 9
Council Bluffs 9
Frankfurt am Main 9
Hanover 9
Helsinki 9
Hải Dương 9
Salerno 9
Biên Hòa 8
Columbus 8
London 8
Shanghai 8
Tianjin 8
Tricesimo 8
Amman 7
Chennai 7
Chicago 7
Dhaka 7
Düsseldorf 7
Hangzhou 7
Tashkent 7
Toronto 7
Viterbo 7
Volla 7
Warsaw 7
Atlanta 6
Auburn Hills 6
Cabo Frio 6
Castelnuovo Cilento 6
Catanzaro 6
Falkenstein 6
Orta di Atella 6
Porto Alegre 6
San Francisco 6
Tokyo 6
Amsterdam 5
Asunción 5
Brooklyn 5
Buenos Aires 5
Can Tho 5
Changsha 5
Charlotte 5
Totale 9.350
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 234
'Role of PI3-K signaling in steroid action’ 191
CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND NERVE GROWTH FACTOR RECEPTOR IN PROSTATE CANCER CELLS: IMPLICATIONS FOR A NEW THERAPEUTIC APPROACH. 185
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 177
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury. 173
Calmodulin-stimulated estradiol receptor-tyrosine kinase I 168
Breast cancer stem cells: The role of sex steroid receptors 165
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 163
Androgen regulation of motility in fibroblasts 163
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 160
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 160
Activation-inactivation of hormone binding sites of the oestradiol-17 beta receptor is a multiregulated process 158
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 157
Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/src association 156
Androgen-induced cell migration: role of androgen receptor/filamin A association. 156
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth 155
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 155
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 154
Integrating signals between cAMP and MAPK pathways in breast cancer 150
Protein tyrosine phosphorylation and estradiol action 150
Epigenetic drugs against cancer: an evolving landscape. 150
Sex steroid hormones act as growth factors 150
Crosstalk between EGFR and extranuclear steroid receptors. 149
Targeting rapid action of sex-steroid receptors in breast and prostate cancers. 149
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 148
Analysis of histone posttranslational modifications in the control of chromatin plasticity observed at estrogen-responsive sites in human breast cancer cells. 147
Advances in Rapid Sex-Steroid Action New Challenges and New Chances in Breast and Prostate Cancers 146
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells through AR/Src/PI3-K Complex Assembly. 146
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 143
'Steroid-activated PI3-K pathway in target cells'. 143
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor a alpha tyrosine-phosphorylated peptide 141
Action of vanadate on estrogen dependent MCF-7 cells. 141
EXTRA-NUCLEAR PARTNERS OF ANDROGEN RECEPTOR: AT THE CROSSROADS OF PROLIFERATION, MIGRATION AND NEURITOGENESIS. 140
Rapid signalling pathway activation by androgens in epithelial and stromal cells 139
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 138
THE DUAL ROLE OF ANDROGEN RECEPTOR IN MESENCHYMAL CELLS. 137
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 137
Phosphoinositide 3-kinase assay in breast cancer cell extracts. 137
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 136
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 136
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 135
Agri-Food By-Products in Cancer: New Targets and Strategies. 134
Binary switch between adjacent marks in histone H3 directs productive transcription in estrogen-induced breast cancer cells upon cyclical creation of ROS. 134
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 131
Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. 131
Src is an initial target of sex steroid hormone action. 131
Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding 129
Cell proliferation regulated by estradiol receptor: therapeutic implications. 129
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 126
Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor β. 125
In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor 125
ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities 125
The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions. 123
Role of the Androgen Receptor in Gender-Related Cancers. 122
Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness. 122
Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines. 122
Prostate cancer stem cells: the role of androgen and estrogen receptors. 122
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 122
A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells 122
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 120
Communication between cells: exosomes as a delivery system in prostate cancer. 120
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 119
The androgen receptor in breast cancer 118
Steroid signaling activation and intracellular localization of sex steroid receptors 117
The role of androgen receptor/filamin A association in androgen-induced cell migration 116
Phosphorylation on tyrosine of oestradiol-17 beta receptor in uterus and interaction of oestradiol-17 beta and glucocorticoid receptors with antiphosphotyrosine antibodies 115
The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment. 114
Androgens as the “old age stick” in skeletal muscle (Correction: Androgens as the “old age stick” in skeletal muscle) 113
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 113
New insights and emerging therapeutic approaches in prostate cancer. 113
Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens 111
Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells 111
Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. 111
Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance 110
Novel aspects of signalling activation by steroid hormones in target cells. 110
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells. 109
Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence 108
The role of androgen receptor in stromal cells. 108
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 108
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 107
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells 106
Non-genomic action of steroid hormones: More questions than answers 106
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 105
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 104
NON-GENOMIC ANDROGEN ACTION REGULATES PROLIFERATIVE/MIGRATORY SIGNALLING IN STROMAL CELLS. 104
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 104
THE ROLE OF THE ANDROGEN RECEPTOR IN SKELETAL MUSCLE SENESCENCE. 102
Filamin A in triple negative breast cancer. 102
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. 101
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. 101
The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. 101
Protein tyrosine phosphorylation and estradiol action 100
Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17 beta receptor. Role of Ca2+-calmodulin in the activation of hormone binding sites 99
P491 THE ANDROGEN RECEPTOR IN HUMAN SKELETAL MUSCLE BIOPSIES 99
Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells 98
Steroid activation of signal transducing pathways. 97
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. 97
Phosphorylation of uterus estradiol receptor on tyrosine 96
ATP-dependent enzyme activating hormone binding of estradiol receptor 93
Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells 93
Totale 12.972
Categoria #
all - tutte 58.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 4 144 125 41 150 117 28
2021/20221.042 71 11 13 30 341 36 27 28 33 91 88 273
2022/20232.338 161 67 36 243 230 234 10 174 1.047 25 60 51
2023/2024967 102 40 29 62 279 51 47 55 13 50 101 138
2024/20252.514 18 25 33 142 381 344 411 185 314 288 199 174
2025/20267.690 468 702 457 409 839 4.815 0 0 0 0 0 0
Totale 17.827